Efficacy of an Occupational Time Use Intervention for People With Serious Mental Illness
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00520728|
Recruitment Status : Completed
First Posted : August 24, 2007
Last Update Posted : September 2, 2015
|Condition or disease||Intervention/treatment||Phase|
|Serious Mental Illness||Behavioral: Occupational Time Use Intervention||Phase 1|
5 Assertive Community Treatment (ACT) Teams from Kingston (n=2), Belleville (n=1), and Ottawa (n=2) will be involved in a 12 week randomized controlled trial of our Time Use Intervention. 20 subjects (4 subjects from each team) will participate in this pilot study and will be treated individually by their ACT team Occupational Therapist (1 OT per ACT Team). This pilot test will help to determine the clinical utility and efficacy of our treatment protocol.
Comparison: Standard ACT treatment with the Occupational Time Use Intervention vs. Standard ACT treatment
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||18 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Efficacy of an Occupational Time Use Intervention|
|Study Start Date :||August 2007|
|Primary Completion Date :||May 2008|
|Study Completion Date :||June 2008|
Experimental arm receives 12 week intervention along with standard care.
Behavioral: Occupational Time Use Intervention
12 week behavioral intervention administered by Occupational Therapists.
- Change in Activity Level using a 2 day (48 hour) time use diary [ Time Frame: Participants were tested at baseline and after 12 weeks of treatment. ]
- Occupational Engagement using 1. 48 hour time use diary for occupational balance, 2. Engagement in Meaningful Activities Survey (EMAS) for meaning of activities, and 3. Profiles of Engagement in People with Schizophrenia (POES) to rate engagement. [ Time Frame: Participants were tested at baseline and after 12 weeks of treatment. ]
- Clinical Utility using feedback from Therapists and Treatment Subjects [ Time Frame: Participants were tested after 12 weeks of treatment. ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00520728
|Principal Investigator:||Megan M Edgelow, MSc||Queen's University|
|Study Director:||Terry Krupa, PhD||Queen's University|